The Cefotaxime Sodium, cataloged under National Stock Number 6505-01-201-2825, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. Government technical data includes 7 specifications, cited from the U.S. Government catalog. 2 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. 2 items share a part number with this NSN in the catalog (possible match — not a government interchangeability claim). Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-201-2825 |
| Item Name | Cefotaxime Sodium |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Status | ACTIVE |
| Administration | INTRAMUSCULAR OR INTRAVENOUS |
| Primary Container Content Quantity | 2.000 GRAMS OF ACTIVE INGREDIENT G |
| Medical Designation and Grade | UNITED STATES PHARMACOPEIA |
| Primary Container Type | VIAL |
| Physical Form | POWDER |
| Active Medicament Medicinal Strength | 2.000 GRAMS CEFOTAXIME EQUIVALENT G |
| Total Primary Container Quantity | 50 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Unit of Issue | PG |
| Reference | Meaning |
|---|---|
| CLAFORAN | 5/9 Secondary reference Hoechst-Roussel Pharmaceuticals Inc |
| NDC00039-0019-50 | 3/9 Design control — primary reference Hoechst-Roussel Pharmaceuticals Inc |
NSN 6505-01-201-2825 is a Cefotaxime Sodium, classified under FSC 6505, Drugs and Biologicals. Status: active.
2 possible matches (shared part number, not a government interchangeability claim): 6505-01-217-0349, 6505-01-234-4432. Verify interchangeability with system specifications before substitution.
Key specifications for 6505-01-201-2825: Administration: INTRAMUSCULAR OR INTRAVENOUS; Primary Container Content Quantity: 2.000 GRAMS OF ACTIVE INGREDIENT G; Medical Designation and Grade: UNITED STATES PHARMACOPEIA; Primary Container Type: VIAL. 7 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.